IQVIA  Inc. logo

IQVIA Inc.

IQV | NYSE
Chart Builder DCF Calculator
$269.12
+$2.70 (+1.01%)
Sep 21, 2026, 1:49 PM ET · Market open

Company Profile

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Key Executives

Name Position
Ari Bousbib Chief Executive Officer & Chairman
Michael J. Fedock Executive Vice President & Chief Financial Officer
Alistair Grenfell President of Commercial Solutions
Duane Sachs Senior Vice President of Corporate Development
Eric Sherbet Executive Vice President, General Counsel & Secretary
James G. Berkshire Executive Vice President of Global Infrastructure & Operations
Jeffrey A. Spaeder Chief Medical & Scientific Officer
Keriann Cherofsky Senior Vice President, Corporate Controller & Chief Accounting Officer
Kerri Joseph Senior VP of Investor Relations & Treasurer
W. Richard Staub President of Research & Development Solutions

Latest SEC Filings

Date Type Title
Sep 04, 2026 4 Filing
Aug 04, 2026 4 Filing
Aug 04, 2026 4 Filing
Aug 03, 2026 144 Filing
Jul 31, 2026 144 Filing
Jul 31, 2026 4 Filing
Jul 31, 2026 4 Filing
Jul 31, 2026 4 Filing
Jul 29, 2026 144 Filing
Jul 29, 2026 144 Filing
View All SEC Filings
IQVIA Inc.
IQVIA  Inc. logo
Country United States
IPO Date May 8, 2013
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 94,000
CEO Ari Bousbib

Contact Details

2400 Ellis Road Durham, North Carolina 27703 United States

Stock Details

Ticker Symbol IQV
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001478242
CUSIP Number 46266C105
ISIN Number US46266C1053
SIC Code 8731

© 2026 bestshares.com. All rights reserved.